Scan how CareTrust REIT’s latest U.K. care home expansion compares with other healthcare landlords by lining up its story against the list of solid balance sheet and fundamentals (26 results).
To own CareTrust REIT, you need to believe it can keep turning a larger, more complex seniors housing and skilled nursing footprint into consistent earnings while managing regulatory and integration headaches. The raised 2026 net income outlook to about $1.54 to $1.57 per share reflects management confidence in how the expanded portfolio is operating right now.
The key near term swing factor is execution on newly added U.K. and U.S. assets without eroding margins through higher G&A or underperforming operators. The biggest current risk is that rapid capital deployment and deeper entry into U.K. care homes could amplify integration and reimbursement uncertainty more quickly than internal systems and personnel can absorb.
The most relevant piece of news is the roughly £1.1 billion agreement with LNT for 45 U.K. care homes, layered on top of about $488 million of other recent deals. For an investor, the central question is whether CareTrust REIT can absorb that volume at the 8.8% blended stabilized yield seen on recent non LNT assets while keeping rent coverage and occupancy steady.
Those staggered U.K. closings through 2027 create a clear operational catalyst. Each handover tests whether underwriting, operator selection, and on the ground regulatory work can hold up at scale. The risk is that any pockets of weaker performance or higher than expected running costs emerge just as the portfolio becomes more U.K. heavy, which would pressure the earnings trajectory associated with the updated 2026 guidance.
CareTrust REIT's current analyst story points to revenues of $970.3 million and earnings of $494.9 million by 2029, based on forecasts that assume revenue expands by 22.9% each year and profit rises from $335.0 million today. This represents an earnings increase of about $159.9 million over that period.
Uncover why CareTrust REIT's fair value indicates a 25% potential upside to its current price, which could narrow quickly.
The Simply Wall St Community only has two fair value views on CareTrust REIT so far, yet they already stretch from about $45.50 to roughly $86.99 per share. Those private estimates do not yet factor in the £1.1b U.K. expansion or higher 2026 earnings guidance; fresh opinions could shift sharply as more investors reassess the integration, regulatory and funding trade offs.
Explore another CareTrust REIT fair value estimate, including one that suggests as much as 140% potential upside from the current price.
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
If the CareTrust REIT story has you thinking about portfolio upgrades, use the Simply Wall St Screener to line up other businesses with financial traits that match your own risk and income goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com